Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By

List of Treatments for Kidney Cancer

See what members are saying about kidney cancer treatments, the side effects to expect, and the drug basics.

All treatment information is medically reviewed · May 21, 2026

Keytruda Qlex (Pembrolizumab and Berahyaluronidase Alfa-Pmph)

Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of kidney cancer, also known as renal cell carcinoma (RCC). It is approved in combination with axitinib…

Fotivda (Tivozanib)

Overview
Fotivda is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma (RCC), a type of kidney cancer, after they have received…

Votrient (Pazopanib)

Overview
Votrient is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC), a form of kidney cancer. It is typically prescribed to adults whose cancer has spread…

Nexavar (Sorafenib)

Overview
Nexavar is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It is typically prescribed for individuals whose cancer is…

Torisel (Temsirolimus)

Overview
Torisel is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC). This therapy is typically used in cases where the cancer has spread and cannot be…

Lenvima (Lenvatinib)

Overview
Lenvima is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma, a form of kidney cancer. It is prescribed in combination with pembrolizumab for adults as a…

Welireg (Belzutifan)

Overview
Welireg is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced renal cell carcinoma (RCC) with a clear cell component. To be eligible, a person must have previously…

Afinitor (Everolimus)

Afinitor (everolimus) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with advanced renal cell carcinoma (RCC) after treatment with sunitinib or sorafenib did not work.

Cabometyx (Cabozantinib)

Overview
Cabometyx is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced renal cell carcinoma (RCC). It may be used either as a single agent or in combination with nivolumab…

Sutent (Sunitinib Malate)

Overview
Sutent is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults. It is also approved as an adjuvant treatment (additional therapy after…

Inlyta (Axitinib)

Overview
Inlyta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It is used in combination with either avelumab or pembrolizumab…

Keytruda (Pembrolizumab)

Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults. It is used in combination with axitinib or lenvatinib as a first-line…

Opdivo (Nivolumab)

Overview
Opdivo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced renal cell carcinoma, a common type of kidney cancer. It can be used as a first-line treatment in…

Yervoy (Ipilimumab)

Overview
Yervoy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults who are considered intermediate- or poor-risk. It is used as a first-line…

Bavencio (Avelumab)

Overview
Bavencio is approved by the U.S. Food and Drug Administration (FDA) as a first-line treatment, in combination with axitinib, for adults with advanced renal cell carcinoma (RCC), a common type of kidney cancer…

Avastin (Bevacizumab)

Overview
Avastin is approved by the U.S. Food and Drug Administration (FDA) for use in treating metastatic renal cell carcinoma (a type of advanced kidney cancer) when given in combination with interferon alfa. This…

Thank you for subscribing!

Become a member to get even more